Home › Funds › Harvest Portfolios Group Inc. › REGN

Harvest Portfolios Group Inc. position in REGN

REGENERON PHARMACEUTICALS · Health Care

Harvest Portfolios Group Inc. reported holding 101,749 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$77.2M, representing 0.97% of its reported portfolio and ranking #31 among its reported holdings. Harvest Portfolios Group Inc. has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)101.75K sh
Reported value held$77.15M
Portfolio Weight0.97%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Harvest Portfolios Group Inc.'s REGN position evolved

Harvest Portfolios Group Inc. first disclosed a stake in REGN in Q3 2023 at 64,602 shares (US$53.2M). The position peaked in Q3 2026 at 101,749 shares, worth US$77.2M. Across 13 filings, Harvest Portfolios Group Inc. increased the stake 5 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 101,749 shares valued at US$77.2M — a reduction of -2,867 shares quarter over quarter.. Notable position changes include a 61% increase in Q4 2024 (shares fell 11% over the following quarter), a 45% increase in Q2 2026 (shares rose 22% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 64.60K $53.16M New
Q4 2023 61.00K $53.58M Reduce
Q1 2024 55.95K $53.86M Reduce
Q2 2024 51.39K $54.01M Reduce
Q3 2024 44.34K $46.61M Reduce
Q4 2024 71.37K $50.84M Add
Q1 2025 82.92K $52.59M Add
Q2 2025 99.00K $51.98M Add
Q3 2025 107.55K $60.47M Add
Q4 2025 81.75K $63.10M Reduce
Q1 2026 72.40K $55.94M Reduce
Q2 2026 104.62K $65.23M Add
Q3 2026 101.75K $77.15M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has Harvest Portfolios Group Inc. held REGN?

Harvest Portfolios Group Inc. has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Harvest Portfolios Group Inc.'s current position in REGN?

As of Q3 2026, Harvest Portfolios Group Inc. holds 101.75K shares of REGN (REGENERON PHARMACEUTICALS), valued at $77.15M, representing 0.97% of its reported portfolio and ranking #31.

Has Harvest Portfolios Group Inc. been buying or selling REGN?

In the latest 13F filing (Q3 2026), Harvest Portfolios Group Inc. reduced its position in REGN. The position peaked in Q3 2026 at 101.75K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.